RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

158 hedge funds and large institutions have $1.66B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12.6M
Puts
$31.7M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$285M
2
$181M
3
$165M
4
$109M
5
$76.1M
6
$75.5M
7
$61.4M
8
$47.6M
9
$43.2M
10
$39.9M
11
$36.5M
12
$34M
13
$29.9M
14
$23.4M
15
$23.1M
16
$22.7M
17
$22.3M
18
$22.2M
19
$18.6M
20
$18.5M
21
$18M
22
$17.4M
23
$12.8M
24
$12.3M
25
$11.8M